Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation

Status Withdrawn

Clinical Trial Summary

The investigators believe dexmedetomidine will provide superior sedation with reduced side effects and reduced time to discharge compared with pentobarbital. The investigators have developed sedation protocols with pentobarbital and dexmedetomidine in our ambulatory procedure center. These protocols are both routinely used for sedation in our unit. The investigators propose to study these two protocols in children ages 6 months to 6 years presenting to the ambulatory procedure center for non-painful procedural sedation. The investigators will compare failure of sedation, side effect profile, recovery and discharge times between the two pharmacologic protocols.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Sedation

Clinical Trial Details

NCT number	NCT00878345
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Withdrawn
Phase	N/A
Start date	November 2009
Completion date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03399019` - Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia	N/A
Completed	`NCT03220880` - Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
Recruiting	`NCT04820205` - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children	N/A
Recruiting	`NCT04549623` - End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography	N/A
Recruiting	`NCT04822064` - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation	N/A
Completed	`NCT01001533` - Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation	N/A
Completed	`NCT01527903` - A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit	Phase 4
Completed	`NCT00747721` - Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU	Phase 1
Completed	`NCT00158873` - Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects	Phase 4
Terminated	`NCT00205517` - Sedation and Psychopharmacology in Critical Care	N/A
Recruiting	`NCT04096768` - The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation	Phase 3
Active, not recruiting	`NCT05082623` - The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters	N/A
Suspended	`NCT03285165` - Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients	Phase 2/Phase 3
Active, not recruiting	`NCT04788589` - Sedation and Ventilator Weaning Protocol in PICU	N/A
Completed	`NCT03425474` - Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy	Phase 3
Recruiting	`NCT06061159` - The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction	Phase 4
Completed	`NCT02171910` - Doxapram as an Additive to Propofol Sedation in Sedation for ERCP	Phase 4
Completed	`NCT02211118` - Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD	Phase 4
Completed	`NCT01694745` - EUROpean Pain Audit In Neonates	N/A
Completed	`NCT00997126` - Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation	Phase 4